May 2022

FDA converts emergency approval of baricitinib — first identified as a COVID treatment by BenevolentAI — to a full approval

The FDA has converted its emergency approval of baricitinib to a full approval, underscoring the strength of BenevolentAI’s AI-derived hypothesis.
Mar 2022

Overcoming stigma and challenges facing women the tech industry

For Women’s History Month we spoke to four women from BenevolentAI’s Leadership Team and explored the barriers, biases and unfair challenges that remain for women in STEM.
Feb 2022

Please don’t use this sentence out of context

BenevolentAI and Stanford University review progress in their AI research partnership, which looks at the role of ​​co​​ntext in information extraction.
Jan 2022

Meet our 2021 intern cohort

We caught up with some of our 2021 cohort to hear about why they chose to #InternAtBenevolent, what they worked on, what they learned and their advice for future interns.